跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Brevoneb - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Brevoneb
Approved
STANDARD
Brevoneb
Ahlcon Parenterals (India) Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a52e7432881b6ac3
Company
Ahlcon Parenterals (India) Limited
Type
Standard
Approval Details
Approval Id
a52e7432881b6ac3
Drug Approval Philippines Name
Brevoneb
Product Name
Brevoneb
Registration Number
DRP-13048
Brand Name
Brevoneb
Generic Name
Salbutamol (as Sulfate) + Ipratropium Bromide
Dosage Form
Solution For Inhalation
Dosage Strength
2.5 mg / 500 mcg per 2.5 mL
Manufacturer
Ahlcon Parenterals (India) Limited
Importer
Ambicare Pharmaceuticals, Inc.
Distributor
Ambicare Pharmaceuticals, Inc.
Issuance Date
24 November 2022
Expiry Date
24 November 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a52e7432881b6ac3
Type
Standard
Back to Philippines FDA Approvals